40 results
DEFM14A
KDNY
Chinook Therapeutics Inc
10 Jul 23
Proxy related to merger
4:01pm
, surface water, groundwater and surface or subsurface strata) or at or from any property.
“Representative” of any Person means such Person’s officers
PREM14A
KDNY
Chinook Therapeutics Inc
27 Jun 23
Preliminary proxy related to merger
4:02pm
, leaching, migration, or other movement or presence in, into or through the indoor or outdoor environment (including ambient air, surface water
DEFA14A
KDNY
Chinook Therapeutics Inc
12 Jun 23
Additional proxy soliciting materials
7:05am
ambient air, surface water, groundwater and surface or subsurface strata) or at or from any property.
“Representative” of any Person means
8-K
EX-2.1
KDNY
Chinook Therapeutics Inc
12 Jun 23
Chinook Therapeutics Enters into Agreement to be Acquired by Novartis AG
7:00am
, surface water, groundwater and surface or subsurface strata) or at or from any property.
“Representative” of any Person means such Person’s officers
8-K
EX-1.1
KDNY
Chinook Therapeutics Inc
25 May 22
Chinook Therapeutics Announces Pricing of a $105 Million Public Offering
4:09pm
of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife
8-K
EX-1.1
5lqk1qguyz
10 Nov 21
Chinook Therapeutics Announces Pricing of an Upsized $160 Million Public Offering
5:24pm
8-K
EX-2.1
lgqwzho
2 Jun 20
Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement
9:19am
425
EX-2.1
pw6k1 w39
2 Jun 20
Business combination disclosure
9:17am